Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT02503709 · COMPLETED
Trial details
- NCT number
- NCT02503709
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-30
- Primary completion
- 2020-08-15
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.